COVID-19
To add the references below to your reference management program: 1. Download the file; 2. Open your reference management program or EndNote; 3. Select File and import |
192 Articles |
-
Phase 2-3 Trial: Prevention of the Progression to Moderate and Severe COVID-19 in SARS-CoV-2-Infected Non-Hospitalized Adults With Inhaled siRNA-Based MIR 19
Khaitov, M., Nikonova, A., Smirnov, V., et al. Allergy. First published: 03 March 2025
-
Notch4 regulatory T cells and SARS-CoV-2 viremia shape COVID19 survival outcome
Benamar M, Lai PS, Huang C-Y, et al. Allergy. First published: 03 October 2024
-
Multimodal profiling of biostabilized human skin modules reveals a coordinated ecosystem response to injected mRNA-1273 COVID-19 vaccine
Scholaert M, Peries M, Braun E, et al. Allergy. First published: 19 August 2024
-
Comparison of upper and lower airway expression of SARS-COV-2 receptors in allergic asthma
Ranjbar, M., Whetstone, C.E., Cusack, R.P., et al. Allergy. First published: 10 May 2024
-
Four years into the COVID-19 pandemic: Timely published articles for patient care and EAACI's leadership role
Torres, M.J., Klimek, L., Agache, I., et al. Allergy. First published: 03 May 2024
-
Long-term follow-up of neutrophil activation after severe-to-critical SARS-CoV-2 infection: A longitudinal study
Valentin, S., Regnault, V., Gueant, J.-L., et al. Allergy. First published: 12 April 2024
-
Prior respiratory syncytial viral infection contributes to severe COVID-19 illness: A nationwide cohort study
Lee, H.J., Kim, M.J., Kim, J.S., Lee, Y.C. and Jeong, J.S. Allergy. First published: 05 April 2024
-
Association between gut microbiota development and allergy in infants born during pandemic-related social distancing restrictions
Korpela K, Hurley S, Ford SA, et al. Allergy. First published: 29 February 2024
-
Four years after the beginning of COVID-19 pandemic and the publication of the first case series
Gao, Y.-d. and Akdis, C.A. Allergy. First published: 25 January 2024
-
Incidence of healthcare utilization for allergic and respiratory infectious diseases in children with asthma before and during the COVID-19 pandemic
Lee, E., Rhee, E.H., Yu, J., et al. Allergy. First published: 23 December 2023
-
Risk of anaphylaxis after COVID-19 vaccination in South Korea: A nationwide self-controlled case series analysis
Yoon, D., Kim, J.H., Jeong, H.E., et al. Allergy. First published: 12 December 2023
-
The association between allergic rhinitis and the risk of coronavirus disease 2019 (COVID-19): A national survey in China
Yang, X., Zhao, J., Sima, Y., et al. Allergy. First published: 21 July 2023
-
Large cohort study shows increased risk of developing atopic dermatitis after COVID-19 disease
Schmitt, J., Ehm, F., Vivirito, A., et al. Allergy. First published: 20 July 2023
-
Disrupted epithelial permeability as a predictor of severe COVID-19 development
Yazici, D, Cagan, E, Tan, G, et al. Allergy. First published: 08 July 2023
-
Value of vaccine and vaccine excipient skin testing to COVID-19 vaccines
Brockow, K., Bent, R. and Biedermann, T. Allergy. First published: 30 June 2023
-
A multicenter time series study on pollen exposure and COVID-19 infection in five cities in China
Yang, X., Zhang, J., Sima, Y., Zhao, J., Wang, X. and Zhang, L. Allergy. First published: 26 April 2023
-
Risk stratification through extensive allergy work-up in COVID-19-mRNA vaccine allergic reactions
Soria, A., Labella, M., Doña, I., et al. Allergy. First published: 27 March 2023
-
Treatment of COVID-19 patients with a SARS-CoV-2-specific siRNA-peptide dendrimer formulation
Khaitov M, Nikonova A, Kofiadi I, et al. Allergy. First published: 31 January 2023
-
Sex-specific differences in immune response to SARS-CoV-2 vaccination vanish with age
Brigger, D., Guntern, P., Jonsdottir, H.R., et al. Allergy. First published: 20 January 2023
-
Severe cutaneous adverse reactions after COVID-19 vaccination: A systematic review
Wu, P.-C., Huang, I.-H., Wang, C.-W., Chung, W.-H. and Chen, C.-B.. Allergy. First published: 10 January 2023
-
The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2
Hartley, G.E., Edwards, E.S.J., Varese, N., et al. Allergy. First published: 21 December 2022
-
COVID-19 pandemic and environment: Not only air pollution
Caminati, M., Guarnieri, G., Marchetti, P., et al. Allergy. First published: 28 November 2022
-
National trends in the prevalence of allergic diseases among Korean adolescents before and during COVID-19, 2009-2021: A serial analysis of the national representative study
Koo, M.J., Kwon, R., Lee, S.W., et al. Allergy. First published: 28 November 2022
-
Recent developments in the immunopathology of COVID-19
Zhang, H.-p., Sun, Y.-l., Wang, Y.-f., et al. Allergy. First published: 24 November 2022
-
Immediate hypersensitivity reactions to anti-SARS-CoV-2 neutralizing monoclonal antibodies: a real-life experience
Franceschini, L. and Farsi, A. Allergy. First published: 16 November 2022
-
Diagnostic accuracy of vaccine and vaccine excpient testing in the setting of allergic reactions to covid-19 vaccines: a systematic review and meta-analysis
Greenhawt, M., Shaker, M., Golden, D.B.K., et al. Allergy. First published: 02 November 2022
-
The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients
Ungar, B., Hartzell, S., Lozano-Ojalvo, D., et al. Allergy. First published: 01 October 2022
-
Implementation of the web-based calculator estimating odds ratio of severe COVID-19 for unvaccinated individuals in a country with high coronavirus-related death toll
Kwasniewski, M., Korotko, U., Chwialkowska, K., et al. Allergy. First published: 21 September 2022
-
Disproportionate rate of female referrals for suspected COVID-19 vaccine allergies
Chiang, V., Kan, A.K.C., Yim, J.S.H., et al. Allergy. First published: 20 September 2022
-
Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines
Palomares, F., Paris, J.L., Labella, M., Doña, I., Mayorga, C. and Torres, M.J. Allergy. First published: 01 August 2022
-
SARS-CoV-2 infection in severe asthma is associated with worsening of COVID-19 through respiratory NLRP3 inflammasome activation
Jeong, J.S., Choi, J.Y., Kim, J.S., et al. Allergy. First published: 24 July 2022
-
Exposure to avian coronavirus vaccines is associated with increased levels of SARS-CoV-2-cross-reactive antibodies
Ardicli, O, Carli, KT, Satitsuksanoa, P, et al. et al. Allergy. First published: 23 July 2022
-
Urticaria and/or angioedema secondary to mRNA COVID-19 vaccines: Updates from a United States case registry
Anvari, S., Samarakoon, U., Fu, X., et al. Allergy. First published: 16 July 2022
-
The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma
Kim, J.G., Zhang, A., Rauseo, A.M., et al. Allergy. First published: 15 July 2022
-
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity
Worm, M., Alexiou, A., Bauer, A., et al. Allergy. First published: 20 June 2022
-
Presentation of airway and general symptoms in COVID-19 caused by dominant SARS-CoV-2 variants: a follow-up on ARIA consensus
et al. Allergy. First published: 14 June 2022
-
Immune-inflammatory proteome of elite ice hockey players before and after SARS-CoV-2 infection
Maurer, D.J., Barletta, E., Heider, A., et al. Allergy. First published: 12 June 2022
-
Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post–infection and post-vaccination cellular SARS-CoV-2-specific immune response
Kratzer, B., Schlax, L.C., Gattinger, P., et al. Allergy. First published: 12 June 2022
-
T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19
Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022
-
Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses
Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 14 May 2022
-
COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab
Francis, C.H.R., Hearn, A.P., Ratnakumar, S., et al. Allergy. First published: 01 May 2022
-
Effect of BTN162b2 and Coronavac boosters on humoral and cellular immunity of individuals previously fully vaccinated with Coronavac against SARS-CoV-2: A longitudinal study
Kuloğlu, Z.E., El, R., Guney-Esken, et al. Allergy. First published: 19 April 2022
-
Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern
Rothen, D.A., Krenger, P.S., Nonic, A., et al. Allergy. First published: 11 April 2022
-
Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern
Rothen, D.A., Krenger, P.S., Nonic, A., et al. Allergy. First published: 11 April 2022
-
Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures
Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022
-
Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants
Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022
-
Are health care policies for COVID-19 evidence-based?
Bonini, S. and Fiorito, S. Allergy. First published: 30 March 2022
-
Virus-related stimuli modulate SARS-CoV-2 entry factor expression in pediatric tonsillar epithelial cells in vitro
Hara, M., Morimoto, N., Watabe, T., et al. Allergy. First published: 29 March 2022
-
Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?
Eberlein, B., Sonja, M., Fischer, J., Darsow, U., Biedermann, T. and Brockow, K. Allergy. First published: 10 March 2022
-
Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization
Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022
-
Has the Spring 2020 lockdown modified the relationship between air pollution and COVID-19 mortality in Europe?
Annesi-Maesano, I., Maesano, C.N., Dessimond, B., et al. Allergy. First published: 25 February 2022
-
Omicron: A SARS-CoV-2 variant of real concern
Gattinger, P., Tulaeva, I., Borochova, K., et al. Allergy. First published: 21 February 2022
-
Comparative assessment of allergic reactions to COVID-19 vaccines in Europe and the United States
Hatziantoniou, S., Anastassopoulou, C., Lampropoulou, V., et al. Allergy. First published: 16 February 2022
-
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses. EAACI task force on eicosanoids consensus report in times of COVID-19
Sokolowska, M., Rovati, G., Diamant, Z., et al. Allergy. First published: 16 February 2022
-
Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19
Sadlier, C., Albrich, W.C., Neogi, et al. Allergy. First published: 12 February 2022
-
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendations
Jutel, M., Torres, M.J., Palomares, O., et al. Allergy. First published: 11 February 2022
-
Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination
Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 06 February 2022
-
Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper
Barbaud, A., Garvey, L.H., Arcolaci, A., et al. Allergy. First published: 02 February 2022
-
Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study
Horn, MP, Jonsdottir, HR, Brigger, D, et al. Allergy. First published: 05 January 2022
-
Mast cell activation is associated with post-acute COVID-19 syndrome
Wechsler, J.B., Butuci, M., Wong, A., Kamboj, A.P. and Youngblood, B.A. Allergy. First published: 25 November 2021
-
Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses
Hein, S, Herrlein, M-L, Mhedhbi, I, et al. Allergy. First published: 25 November 2021
-
The form of PEG matters: PEG conjugated with lipids and not PEG alone could be the specific form involved in allergic reactions to COVID-19 vaccines
Cabanillas, B., Novak, N. and Akdis, C.A. Allergy. First published: 24 November 2021
-
Childhood BCG vaccination seems to selectively protect adult males from COVID-19 infection
Jansson, M.K., Neuber, K., Rudolf, H., Podbielski, A., Virchow, J.C. and Warnke, P. Allergy. First published: 23 November 2021
-
Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis
Brockow, K., Mathes, S., Fischer, J., et al. Allergy. First published: 22 November 2021
-
COVID-19 vaccines tolerated in patients with paclitaxel and docetaxel allergy
Banerji, A., Wolfson, A.R., Robinson, L.B., et al. Allergy. First published: 14 November 2021
-
Determinants of expression of SARS-CoV-2 entry-related genes in upper and lower airways
Aliee, H., Massip, F., Qi, C., et al. Allergy. First published: 26 October 2021
-
The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine
Labella, M., Céspedes, J.A., Doña, I., et al. Allergy. First published: 24 October 2021
-
RBD-IgG levels correlate with protection in residents facing SARS-CoV-2 B.1.1.7 outbreaks
Blain, H., Tuaillon, E., Gamon, L., et al. Allergy. First published: 15 October 2021
-
Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19
Zahn, T., Mhedhbi, I., Hein, S., et al. Allergy. First published: 12 October 2021
-
What we know and still ignore on COVID-19 immune pathogenesis and a proposal based on the experience of allergic disorders
Maggi, E, Azzarone, BG, Canonica, GW, Moretta, L. Allergy. First published: 28 September 2021
-
COVID-19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies
Declercq, J., Tobback, E., Vanhee, S., et al. Allergy. First published: 20 September 2021
-
Development and preclinical evaluation of virus-like particle vaccine against COVID-19 infection
Yilmaz, IC, Ipekoglu, EM, Bulbul, A, et al. Allergy. First published: 14 September 2021
-
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2
Mohsen, MO, Balke, I, Zinkhan, S, et al. Allergy. First published: 08 September 2021
-
Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes
Gattinger, P., Niespodziana, K., Stiasny, K., et al. Allergy.First published: 28 August 2021
-
In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion
Augusto, G, Mohsen, MO, Zinkhan, S, Liu, X, Vogel, M, Bachmann, MF. Allergy. First published: 28 August 2021
-
Antiviral response in vernal keratoconjunctivitis may be protective against COVID-19
Leonardi, A., Rosani, U., Cavarzeran, F., Daull, P., Garrigue, J.-S. and Paola, B. Allergy.First published: 14 August 2021
-
A single dose of BNT162b2 vaccine elicits strong humoral response in SARS-CoV-2 seropositive individuals
Brnjarchevska Blazhevska, T., Babačić, H., Sibinovska, O., et al. Allergy.First published: 12 August 2021
-
Safe administration of the Pfizer-BioNtTech COVID-19 vaccine following an immediate reaction to the first dose
Kessel, A., Bamberger, E., Nachshon, L., Rosman, Y., Confino-Cohen, R. and Elizur, A. Allergy.First published: 09 August 2021
-
Inhaled Corticosteroids in early COVID-19 – a tale of many facets
Klimek, L., Akdis, C.A., Jutel, M., Zuberbier, T. and Bousquet, J. Allergy.First published: 09 August 2021
-
Adverse COVID-19 Outcomes in Immune Deficiencies; Inequality Exists Between Subclasses
Karakoc Aydiner, E., Bilgic Eltan, S., Babayeva, R., et al. Allergy.First published: 27 July 2021
-
Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study
Blain, H, Tuaillon, E, Gamon, L, et al.ss Allergy.First published: 19 July 2021
-
A bird's eye view on the role of dendritic cells in SARS-CoV-2 infection: perspectives for immune-based vaccines
Galati, D., Zanotta, S., Capitelli, L. and Bocchino, M. Allergy.First published: 10 July 2021
-
Molecular definition of severe acute respiratory syndrome coronavirus 2 receptor-binding domain mutations: Receptor affinity versus neutralization of receptor interaction
Vogel, M, Augusto, G, Chang, X, et al. Allergy.First published: 08 July 2021
-
COVID-19 vaccines - the way forward
Klimek, L., Agache, I., Cooke, E., Jutel, M., Akdis, C.A. and O'Hehir, R. Allergy. First published: 30 June 2021
-
One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2
Korath, ADJ, Janda, J, Untersmayr, E, et al. Allergy.First published:28 June 2021
-
Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients
Mitamura, Y., Schulz, D., Oro, S., et al. Allergy.First published:22 June 2021
-
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A., Théophile, H., Sanchez-Pena, P., et al. Allergy.First published: 18 June 2021
-
Delayed local reactions after the first administration of the ChAdOx1 nCoV-19 vaccine
Shin, E., Bae, S., Jung, J., et al. Allergy.First published: 15 June 2021
-
Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19
Eggert, LE, He, Z, Collins, W, et al. Allergy.First published: 03 June 2021
-
Adding the variable of environmental complexity into the COVID-19 pandemic equation
Damialis, A., Gilles, S. and Traidl-Hoffmann, C. Allergy. First published: 28 May 2021
-
Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose!
Krantz, M.S., Bruusgaard-Mouritsen, M.A., Koo, G., et al. Allergy. First published: 24 May 2021
-
Long-term disruption of cytokine signalling networks is evident in patients who required hospitalization for SARS-CoV-2 infection
Ahearn-Ford, S., Lunjani, N., McSharry, B., et al. Allergy. First published: 24 May 2021
-
Caspases and therapeutic potential of caspase inhibitors in moderate–severe SARS CoV2 infection and long COVID
Plassmeyer, M, Alpan, O, Corley, MJ, et al. Allergy. First published: 15 May 2021
-
ACE2 downregulation in olfactory mucosa: eosinophilic rhinosinusitis as COVID-19 protective factor?
Marin, C., Tubita, V., Langdon, C. et al. Allergy. First published: 13 May 2021
-
BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection but recognition of mutant viruses is up to 10-fold reduced
Chang, X., Augusto, G.S., Liu, X. et al. Allergy. First published: 05 May 2021
-
Asia-Pacific perspectives on the COVID-19 pandemic
Pawankar, R., Yu-Hor Thong, B., Tiongco-Recto, M., Wang, J.-Y., Hamzah Abdul Latiff, A., Thien, F. et al. Allergy. First published: 04 May 2021
-
Adherence to subcutaneous immunotherapy with aeroallergens in real-life practice during the COVID-19 pandemic
Yeğit, O.O., Demir, S., Ünal, D., Olgaç, M., Terzioğlu, K., Eyice Karabacak, D. et al. Allergy. First published: 27 April 2021
-
Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID-19 vaccines in Europe
Wagner, R., Meißner, J., Grabski, E., Sun, Y., Vieths, S. and Hildt, E. Allergy. First published: 22 April 2021
-
Profound dysregulation of T cell homeostasisand function in patients with severe COVID-19
Adamo, S., Chevrier, S., Cervia, C., Zurbuchen, Y., Raeber, M.E., Yang, L. et al. Allergy. First published: 21 April 2021
-
Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer for
Khaitov, M., Nikonova, A., Shilovskiy, I., Kozhikhova, K., Kofiadi, I., Vishnyakova, L. et al. Allergy. First published: 10 April 2021
-
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., Jutel, M., Ventura, M.T., Worm, M. et al. Allergy. First published: 02 April 2021
-
Allergenic components of the mRNA-1273 vaccine for COVID-19: possible involvement of polyethylene glycol and IgG-mediated complement activation
Klimek, L., Novak, N., Cabanillas, B., Jutel, M., Bousquet, J. and Akdis, C.A. Allergy. First published: 03 March 2021
-
COVID-19 pandemic and allergen immunotherapy – an EAACI survey
Pfaar, O., Agache, I., Bonini, M., Brough, H.A., Chivato, T., Del Giacco, S.R. et al. Allergy. First published: 02 March 2021
-
Deletion of BCG_2432c from the Bacillus Calmette-Guérin vaccine enhances autophagy-mediated immunity against tuberculosis
Wu, Y., Tian, M., Zhang, Y., et al. Allergy. First published: 27 October 2021
-
Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19
Adamo, S., Chevrier, S., Cervia, C., et al. Allergy.2021; 76: 2866-2881
-
Pros and cons for the role of air pollution on COVID-19 development
Annesi-Maesano, I., Maesano, C.N., D’Amato, M. and D’Amato, G. Allergy. 2021; 76: 2647-2649
-
Real-life impact of COVID-19 pandemic lockdown on the management of pediatric and adult asthma: A survey by the EAACI Asthma Section
Eguiluz-Gracia, I., van den Berge, M., Boccabella, C., et al. Allergy. 2021; 76: 2776-2784
-
Anaphylaxis in the Emergency Department Unit: Before and during COVID-19
Pur Ozyigit, L., Khalil, G., Choudhry, T., Williams, M. and Khan, N. Allergy. 2021; 76: 2624-2626
-
Skin tests in urticaria/angioedema and flushing to Pfizer-BioNTech SARS-CoV-2 vaccine: Limits of intradermal testing
Bianchi, L., Biondi, F., Hansel, K., Murgia, N., Tramontana, M. and Stingeni, L. Allergy. 2021; 76: 2605-2607
-
Detection of SARS-CoV-2-specific memory B cells to delineate long-term COVID-19 immunity
Thieme, C.J., Abou-el-Enein, M., Fritsche, E., Anft, M., Paniskaki, K., Skrzypczyk, S. et al. Allergy. 2021; 76: 2595-2599
-
Impact of anxiety, stress and depression related to COVID-19 pandemic on the course of hereditary angioedema with C1 inhibitor deficiency
Eyice Karabacak, D., Demir, S., Yeğit, O.O., Can, A., Terzioğlu, K., Ünal, D. et al. Allergy. 2021; 76: 2535-2543
-
Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients
Zhang, J-J, Cao, Y-Y, Tan, G, et al. Allergy. 2021; 76: 533– 550
-
Multidisciplinary consensus on sputum induction biosafety during the COVID-19 pandemic
Crespo-Lessmann, A., Plaza, V. Allergy. 2021; 76: 2407-2419
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus
Hagemann, J., Onorato, G.L., Jutel, M., et al.Allergy. 2021; 76: 2354-2366
-
Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines
Borgsteede, S.D., Geersing, T.H. and Tempels-Pavlica, Ž. Allergy. 2021; 76: 1941-1942
-
SARS-CoV-2 candidate vaccines - composition, mechanisms of action and stages of clinical development
Rodriguez-Coira, J. and Sokolowska, M. Allergy. 2021; 76: 1922-1924
-
Association of endopeptidases, involved in SARS-CoV-2 infection, with microbial aggravation in sputum of severe asthma
Abdel-Aziz, M.I., Kermani, N.Z., Neerincx, A.H., Vijverberg, S.J.H., Guo, Y., Howarth, P. et al. Allergy. 2021; 76: 1917-1921
-
Enzymatic activity of ACE2 regulates type 2 airway inflammation in mice
Fukuda, A., Toyoshima, S., Yamada, S. et al. Allergy. 2021; 76: 1913-1917
-
Genetic predisposition to allergic diseases is inversely associated with risk of COVID-19
Larsson, S.C. and Gill, D. Allergy. 2021; 76: 1911-1913
-
Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19
Guéant, J.-L., Guéant-Rodriguez, R.-M., Fromonot, J., Oussalah, A., Louis, H., Chery, C. et al. Allergy. 2021; 76: 1846-1858
-
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry
Chiricozzi, A., Talamonti, M., De Simone, C., Galluzzo, M., Gori, N., Fabbrocini, G. et al. Allergy. 2021; 76: 1813-1824
-
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multinational cohort
Papadopoulos, N.G., Mathioudakis, A.G., Custovic, A., Deschildre, A., Phipatanakul, W., Wong, G. et al. Allergy. 2021; 76: 1765-1775
-
Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
Sokolowska, M., Eiwegger, T., Ollert, M., Torres, M.J., Barber, D., Del Giacco, S. et al. Allergy. 2021; 76: 1629-1639
-
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA position paper
Klimek, L., Jutel, M., Akdis, C.A., Bousquet, J., Akdis, M., Torres-Jaen, M. et al. Allergy. 2021; 76: 1624-1628
-
Allergic reactions to COVID-19 -vaccinations – unveiling the secret(s)
Pfaar, O. and Mahler, V. Allergy. 2021; 76: 1621-1623
-
Allergic reactions to the first COVID-19 vaccine: a potential role of polyethylene glycol?
Cabanillas, B., Akdis, C. and Novak, N. Allergy. 2021; 76: 1617-1618
-
Regional differences in ACE2 expression in the sinonasal mucosa of adult Chinese patients with chronic rhinosinusitis
Wang, H., Song, J., Pan, L., et al. Allergy. 2021; 76: 1565-1568
-
Asthmatic patients and COVID-19: Different disease course?
Alberca, R.W., Yendo, T., Aoki, V. and Sato, M.N. Allergy. 2021; 76: 963-965
-
Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology
Bhalla, A., Mukherjee, M., Radford, K., et al. Allergy. 2021; 76: 957-958
-
Could anti-tubercular vaccination protect against COVID-19 infection?
Patella, V., Florio, G., Brancaccio, R. and Delfino, G. Allergy. 2021; 76: 942-945
-
The role of circulating eosinophils on COVID-19 mortality varies by race/ethnicity
Glickman, J.W., Pavel, A.B., Guttman-Yassky, E. and Miller, R.L. Allergy. 2021; 76: 925-927
-
Association between asthma and clinical mortality/morbidity in COVID-19 patients using clinical epidemiologic data from Korean Disease Control and Prevention
Choi, H.-G., Wee, J.H., Kim, S.Y. et al. Allergy, 76: 921-924
-
Characterization of asthma and risk factors for delayed SARS-CoV-2 clearance in adult COVID-19 inpatients in Daegu
Kim, S., Jung, C.-G., Lee, J.Y., et al. Allergy. 2021; 76: 918-921
-
Small droplet emission in exhaled breath during different breathing manoeuvres: Implications for clinical lung function testing during COVID-19
Greening, N.J., Larsson, P., Ljungström, E., Siddiqui, S. and Olin, A.-C. Allergy. 2021; 76: 915-917
-
Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: all mild course
Larenas-Linnemann, D.E. and Rodríguez-Monroy, F. Allergy, 76: 910-914
-
Angiotensin-converting enzyme II expression and its implication in the association between COVID-19 and allergic rhinitis
Wang, H., Song, J., Yao, Y., et al. Allergy. 2021; 76: 906-910
-
Severe asthma in adults does not significantly affect the outcome of COVID-19 disease: results from the Italian Severe Asthma Registry
Antonicelli, L., Tontini, C., Manzotti, G., et al. Allergy. 2021; 76: 902-905
-
Atopic status protects from severe complications of COVID-19
SScala, E., Abeni, D., Tedeschi, A., et al. Allergy.2021; 76: 899-902
-
Blood myeloperoxidase-DNA, a biomarker of early response to SARS-CoV-2 infection?
Guéant, J.-L., Fromonot, J., Guéant-Rodriguez, R.-M., Lacolley, P., Guieu, R. and Regnault, V. Allergy. 2021; 76: 892-896
-
Cross-sectional pilot study exploring the feasibility of a rapid SARS-CoV-2 immunization test in health and non-healthcare workers
Escribese, M.M., Nistal-Villan, E., Fernandez, P., et al. Allergy. 2021; 76: 896-899
-
COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments
Heffler, E., Detoraki, A., Contoli, M., et al. Allergy. 2021; 76: 887-892
-
Bacillus Calmette-Guérin vaccination and socioeconomic variables vs COVID-19 global features: Clearing up a controversial issue
Ventura, L., Vitali, M. and Romano Spica, V. Allergy. 2021; 76: 884-887
-
Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus receptor binding
Gattinger, P., Borochova, K., Dorofeeva, Y., et al. Allergy. 2021; 76: 878-883
-
SARS-CoV-2 receptor ACE2 protein expression in serum is significantly associated with age
Pavel, A.B., Wu, J., Renert-Yuval, Y., et al. Allergy. 2021; 76: 875-878
-
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey
Matucci, A., Caminati, M., Vivarelli, E., et al. Allergy.2021; 76: 871-874
-
Telemedicine allows quantitative measuring of olfactory dysfunction in COVID-19
Klimek, L., Hagemann, J., Alali, A., et al. Allergy. 2021; 76: 868-870
-
Is asthma protective against COVID-19?
Carli, G., Cecchi, L., Stebbing, J., Parronchi, P. and Farsi, A. Allergy. 2021; 76: 866-868
-
Accuracy of serological testing for SARS-CoV-2 antibodies: first results of a large mixed-method evaluation study
Brigger, D, Horn, MP, Pennington, LF, et al. Allergy. 2021; 76: 853– 865
-
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria
Kocatürk, E, Salman, A, Cherrez-Ojeda, I, et al. Allergy. 2021; 76: 816– 830
-
Distinct expression of SARS-CoV-2 receptor ACE2 correlates with endotypes of chronic rhinosinusitis with nasal polyps
Wang, M, Bu, X, Fang, G, et al. Allergy. 2021; 76: 789– 803
-
Immunological imprint of COVID-19 on human peripheral blood leukocyte populations
Kratzer, B, Trapin, D, Ettel, P, et al. Allergy. 2021; 76: 751– 765
-
Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
Bousquet, J, Anto, JM, Czarlewski, W, et al. Allergy. 2021; 76: 735– 750
-
SARS-CoV-2, COVID-19, skin and immunology - what do we know so far?
Novak, N, Peng, W, Naegeli, MC, et al. Allergy. 2021; 76: 698– 713
-
ARIA-EAACI statement on asthma and COVID-19
Bousquet, J., Jutel, M., Akdis, C.A. et al. Allergy. 2021; 76: 689-697
-
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic – An EAACI position paper
Klimek, L, Jutel, M, Bousquet, J, et al. Allergy. 2021; 76: 677– 688
-
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic – an EAACI/ARIA position paper
Pfaar, O, Klimek, L, Jutel, M, et al. Allergy. 2021; 76: 648– 676
-
Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19
Andreakos, E., Papadaki, M. and Serhan, C.N. Allergy. 2021; 76: 626-628
-
COVID-19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS-CoV-2 infection and care of allergy patients
Pfaar, O., Torres, M.J. and Akdis, C.A. Allergy. 2021; 76: 622-625
-
Delayed virus-specific antibody responses associate with COVID-19 mortality
Wang, F., Yao, Y., Hou, H., et al. Allergy.2021; 76: 574-577
-
Asthma control, self-management and healthcare access during the COVID-19 epidemic in Beijing
Chang, C., Zhang, L., Dong, F., et al. Allergy. 2021; 76: 586-588
-
COVID-19 and asthma, the good or the bad?
Wang, J.-Y., Pawankar, R., Tsai, H.-J., Wu, L.S.-H. and Kuo, W.-S. Allergy. 2021; 76: 565-567
-
Eosinopenia is associated with greater severity in patients with coronavirus disease 2019
Zhao, L., Zhang, Y.-p., Yang, X. and Liu, X. Allergy. 2021; 76: 562-564
-
Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections
Lei, Q, Li, Y, Hou, H-Y, et al. Allergy. 2021; 76: 551– 561
-
Clinical, radiological and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients
Zhang, J-J, Cao, Y-Y, Tan, G, et al. Allergy. 2021; 76: 533– 550
-
Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status
Du, H, Dong, X, Zhang, J-J, et al. Allergy. 2021; 76: 510– 532
-
Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19
Song, J, Zeng, M, Wang, H, et al. Allergy. 2021; 76: 483– 496
-
The role of peripheral blood eosinophil counts in COVID-19 patients
Xie, G, Ding, F, Han, L, et al. Allergy. 2021; 76: 471– 482
-
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
-
Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Radzikowska, U, Ding, M, Tan, G, et al. Allergy. 2020; 75: 2828– 2844
-
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19
Gelincik, A, Brockow, K, Çelik, GE, et al. Allergy. 2020; 75: 2775– 2793
-
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: an EAACI statement
Vultaggio, A, Agache, I, Akdis, CA, et al. Allergy. 2020; 75: 2764– 2774
-
COVID-19 in a patient with severe asthma treated with omalizumab
Lommatzsch, M., Stoll, P. and Virchow, J.C. Allergy. 2020; 75: 2705-2708
-
Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19
Avdeev, S., Moiseev, S., Brovko, M., et al. Allergy.2020; 75: 2703-2704.
-
COVID-19 clinical trials: quality matters more than quantity
Bonini, S, Maltese, G. Allergy. 2020; 75: 2542– 2547
-
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C, Comberiati, P, Giovannini, M, et al.Allergy. 2020; 75: 2503– 2541
-
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)
Sokolowska, M, Lukasik, ZM, Agache, I, et al. Allergy. 2020; 75: 2445– 2476.
-
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
Bousquet, J., Akdis, C.A., Jutel, M., et al. Allergy. 2020; 75: 2440-2444
-
Clinical characteristics of COVID-19 patients combined with allergy
Shi, W., Gao, Z., Ding, Y., Zhu, T., Zhang, W. and Xu, Y. Allergy.2020; 75: 2405-2408
-
Allergy and asthma in children and adolescents during the COVID outbreak: what we know and how we could prevent allergy and asthma flares?
Licari, A., Votto, M., Brambilla, I., et al. Allergy. 2020; 75: 2402-2405
-
Managing ocular allergy in the time of COVID-19
Leonardi, A., Fauquert, J.L., Doan, S., et al. Allergy. 2020; 75: 2399-2402
-
Is BCG vaccination affecting the spread and severity of COVID-19?
Ozdemir, C., Kucuksezer, U.C. and Tamay, Z.U. Allergy. 2020; 75: 1824-1827
-
COVID-19, chronic inflammatory respiratory diseases and eosinophils – Observations from reported clinical case series
Jesenak, M., Banovcin, P. and Diamant, Z. Allergy. 2020; 75: 1819-1822
-
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Gursel, M. and Gursel, I. Allergy. 202; 75: 1815-1819
-
Advanced forecasting of SARS-CoV-2-related deaths in Italy, Germany, Spain, and New York State
Sotgiu, G., Gerli, A.G., Centanni, S., et al. Allergy. 2020; 75: 1813-1815
-
Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2
Zhang, J.-j., Cao, Y.-y., Dong, X., et al. Allergy. 2020; 75: 1809-1812
-
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q, Huang, D, Ou, P, et al. Allergy. 2020; 75: 1742– 1752
-
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J-J, Dong, X, Cao, Y-Y, et al. Allergy. 2020; 75: 1730– 1741
-
Eleven faces of coronavirus disease 2019
Dong, X, Cao, Y-Y, Lu, X-X, et al. Allergy. 2020; 75: 1699– 1709
-
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, AK, Akdis, M, Azkur, D, et al. Allergy. 2020; 75: 1564– 1581
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
Klimek, L, Jutel, M, Akdis, C, et al. Allergy. 2020; 75: 1546– 1554
-
Asthma and COVID-19: is asthma a risk factor for severe outcomes?
Johnston, S.L. Allergy. 2020; 75: 1543-1545